×
About 1,838 results

ALLMedicine™ Poliomyelitis Center

Research & Reviews  630 results

Catch-up vaccination campaign in children between 6 and 8 years old during COVID-19 pan...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098956
Vaccine Mancarella M, Natarelli F et. al.

May 16th, 2022 - COVID-19 has led to disruption in routine immunization programs around the world. Effective strategies need to be developed to address the decline in vaccine coverage to avoid preventable disease outbreaks. Our study reports a 4-days campaign for ...

Study to Evaluate the Immune Response After Booster Vaccination With Tdap-IPV Vaccine (Against Tetanus, Diphtheria, Pertussis and Poliomyelitis) in Children Who Received Different Pertussis Primary...
https://clinicaltrials.gov/ct2/show/NCT04300192

May 9th, 2022 - Study duration per participant will be approximately 30 days including: 1 day of screening and vaccination, a phone call and a safety follow-up/end of study visit, at Day 8 and Day 30 after vaccine administration, respectively.

Degenerative Myelopathy and Neuropathy in NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) Mice C...
https://doi.org/10.1177/01926233221091747
Toxicologic Pathology; Yang P, Freeman ZT et. al.

Apr 23rd, 2022 - Following implantation of patient-derived xenograft (PDX) breast carcinomas from three separate individuals, 33/51 female NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice presented with progressive, unilateral to bilateral, ascending hindlimb paresis t...

Suboptimal Serologic Immunity Against Poliomyelitis Among New Migrant Children in Greec...
https://doi.org/10.1007/s10903-022-01363-3 10.3892/etm.2017.5009 10.1097/INF.0b013e3182a11526
Journal of Immigrant and Minority Health; Ioannidou C, Galanis P et. al.

Apr 21st, 2022 - Migration-flows pose the risk of poliovirus reintroduction from endemic countries to Greece. This study aims to evaluate serologic-immunity/vaccination against poliomyelitis in newly-arriving migrant children. Demographic-immunisation data and blo...

Vaccination of Ukrainian Refugees: Need for Urgent Action.
https://doi.org/10.1093/cid/ciac276
Clinical Infectious Diseases : an Official Publication Of... Rzymski P, Falfushynska H et. al.

Apr 19th, 2022 - The unprovoked aggression of Russian military forces on Ukraine in February 2022 has caused a high influx of refugees, including children, to neighboring countries, particularly Poland. This caused additional pressures on the healthcare system and...

see more →

Drugs  26 results see all →

Clinicaltrials.gov  29 results

Study to Evaluate the Immune Response After Booster Vaccination With Tdap-IPV Vaccine (Against Tetanus, Diphtheria, Pertussis and Poliomyelitis) in Children Who Received Different Pertussis Primary...
https://clinicaltrials.gov/ct2/show/NCT04300192

May 9th, 2022 - Study duration per participant will be approximately 30 days including: 1 day of screening and vaccination, a phone call and a safety follow-up/end of study visit, at Day 8 and Day 30 after vaccine administration, respectively.

Immunogenicity and Safety of Concomitant and Non-Concomitant Administration of RotaTeq® (V260) and Inactivated Poliomyelitis Vaccine in Healthy Chinese Infants (V260-074)
https://clinicaltrials.gov/ct2/show/NCT04481191

Mar 31st, 2022 - This study will evaluate the immunogenicity and safety of concomitant administration of RotaTeq® (V260) and inactivated poliomyelitis vaccine (IPV) in Chinese infants. Its primary objective is to demonstrate that the immunogenicity of IPV in the c...

Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines
https://clinicaltrials.gov/ct2/show/NCT04529538

Feb 8th, 2022 - This multicenter trial is the first-in-human assessment of two novel oral polio vaccines for poliovirus type 1 and type 3. It will be an 8-arm, randomized, observer-blind, controlled trial, with Sabin monovalent vaccines serving as the control for...

Safety Observation of Enterovirus 71 Inactivated Vaccine (Vero Cell) Combined Immunization in Shanghai
https://clinicaltrials.gov/ct2/show/NCT05166044

Feb 2nd, 2022 - This study is an open clinical trial in children aged 6-71 months old. The purpose of this study is to evaluate the safety of EV71 vaccine (Vero cell), inactivated co-administration with other vaccines.The EV71 vaccine was manufactured by Sinovac ...

Phase 1 Novel Live Attenuated Serotype 2 Oral Polio Vaccine Study in Inactivated Polio Vaccine (IPV) Primed Adults
https://clinicaltrials.gov/ct2/show/NCT03430349

Feb 4th, 2021 - Two nOPV2 vaccine candidates have been developed as attenuated serotype 2 polioviruses derived from a modified Sabin 2 infectious complementary deoxyribonucleic acid (cDNA) clone. nOPV2 Candidate 1 (S2/cre5/S15domV/rec1/hifi3) and nOPV2 Candidate ...

see more →

News  48 results

The COVID-19 Child Pioneers: A Note of Gratitude to the Children and Their Parents
https://www.medscape.com/viewarticle/954552

Jul 15th, 2021 - I overheard a conversation between teachers regarding the COVID-19 vaccine as I was waiting in line to pick up my 3-year-old daughter from daycare. "I will get the vaccine but not my kids." "Absolutely. They're kids, not guinea pigs." "I have alre...

Upcoming vaccine may offset surge in polio subtypes
https://www.mdedge.com/infectiousdisease/article/218291/international-id/upcoming-vaccine-may-offset-surge-polio-subtypes
Heidi Splete

Mar 3rd, 2020 - Although wild poliovirus type 3 has not been detected globally for 7 years, the number of wild type 1 cases increased from 33 in 2018 to 173 in 2019. In response, a modified oral vaccine is being developed, according to Stephen Cochi, MD, of the C.

Kaposi Sarcoma in a Patient With Postpolio Syndrome
http://www.mdedge.com/dermatology/article/213042/infectious-diseases/kaposi-sarcoma-patient-postpolio-syndrome
Melodi Javid Whitley, MD, PhD, Willis Barrow, MD et. al.

Nov 25th, 2019 - Kaposi sarcoma (KS) is a low-grade vascular tumor that is rare among the general US population, with an incidence rate of less than 1 per 100,000. 1 The tumor is more common among certain groups of individuals due to geographic differences in the p.

The Art and Science of JAMA, Then and Now
https://www.medscape.com/viewarticle/912737

May 15th, 2019 - This transcript has been edited for clarity. Hello and welcome. I'm Dr George Lundberg and this is At Large at Medscape.* Many of you may know that I had the great privilege of being the editor-in-chief of JAMA (the Journal of the American Medical...

FDA Clears New GamaStan Immune Globulin for Measles, Hep A Exposure
https://www.medscape.com/viewarticle/901764

Sep 10th, 2018 - The US Food and Drug Administration (FDA) has approved a new formulation of Grifols' GamaSTAN immune globulin (human) for prophylaxis following exposure to hepatitis A virus (HAV) and for prevention or modification of measles in susceptible indivi...

see more →

Patient Education  2 results see all →